Please assess the completion status of the following clinical trial:

Trial Title: SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~* Age 18 years or greater;~* Left Main CAD, defined as ≥ 50% diameter stenosis and amenable to re-vascularization by PCI;~* Willing and able to give informed consent. The patients must be able to comply with study procedures and follow-up.~* Ability to comply with minimum of 6 months of DAPT after the index procedure.~* Unprotected Left Main PCI~* Protected Left Main PCI~Exclusion criteria:~* Coexisting conditions that limit life expectancy to less than 12 months or that could affect patient's compliance with the protocol;~* Serum creatinine greater than 2.0 mg/dL;~* Cardiogenic shock;~* STEMI;~* Non-STEMI, if the cardiac troponin is not stable or starting to decline;~* Pregnancy;~* Inability to take dual antiplatelet therapy for 6 months;~* Any target lesion with previously placed stent.~* Patients disqualified for CABG surgery.~* Contraindications for OCT use:~  1. Bacteremia or sepsis~ 2. Major coagulation system abnormalities~ 3. Severe hemodynamic instability or shock~ 4. Patients diagnosed with coronary artery spasm~ 5. Acute renal failure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Optical Coherence Tomography (Type: OTHER): Patients who have undergone clinically-indicated PCI of LM where OCT was performed as part of the routine index procedure will be approached for the study and enrolled if eligible.

Based on this trial design, predict the completion outcome and termination type (if applicable).